Background and Objectives: Tuberculosis and sarcoidosis are two diseases showing histological and
BACKGROUND
Platelets (PLT) play a crucial role in antimicrobial host defenses and the coagulatin system (1) . It is known that thrombocytosis exist in tuberculosis and increase in thrombocyte count correlated with severity of disease (2) . There is also a significant correlation betweeen the degree of thrombocytosis and acute phase reactans as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in pulmonary tuberculosis (3) (4) . The mean platelet volume (MPV) reflects the size of platelets and correlate with function and activation of plateletes (5) (6) . The importance of MPV has been emphasized as an inflammation marker in some chronic inflammatory diseases and inverse correlation between disease activity and MPV has been demonstrated (7) (8) (9) (10) .
Tuberculosis and sarcoidosis are both granulomatous diseases and can present wih similar symptomatology (11) . Because the differiantial diagnosis of tuberculosis and sarcoidosis is difficult, new markers for differiantion are being investigated (12) .
PLT and MPV values in sarcoidosis were not well studied. The research of this study is to determine whether PLT and MPV can be used as a differiantial marker between sarcoidosis and tuberculosis.
METHODS
A retrospective observational cohort study was conducted at a chest disease and thoracic surgery teaching and research hospital. This study protocol was approved by the institution's ethics committee and was in accordance with the Declaration of Helsinki.
Patients with sarcoidosis (group 1, n:100), patients with tuberculosis (group 2, n:83) , and healty subjects (group 3, n:36) were included in the study. Data was collected from the The exclusion criteria were, haematological disease, hepatic and renal or autoimmune disorders, cardiovasculer disease, systemic arterial hypertension, endocrinological disorders, cancer and immunosuppressive conditions. None of the enrolled subjects had received anticoagulant medications, NSAID sor contraceptives (11) (12) .
Full blood counts were carried out using Beckman Coulter haematologanalyser (TokyoJapan), ESR (eritrocyte sedimentation rate) with Alifax ESR analyser (Polverara-Italy) and serum levels of CRP (C-Reactive Protein) with Garnet-Sıemens (Germany) devices in all groups.
Statistical Analysis
Statistical analysis were performed using NCSS ( comparison of three groups with normal distribution and Tukey HSD test and Tamhane test was used in the determination of the group that cause differences. Kruskal-Wallis test was used in comparison of three groups with non-normal distribution and Mann-Whitney U test was used in the determination of the group that cause differences. In the comparison of qualitative data Pearson Chi-square test was used. Significance was considered at p < 0.01 and p < 0.05 values.
RESULTS
Eligible 219 patients were included in the study. The ages of the patients ranged from 18 to 80 , mean age was 45.17 ± 18.66 years. Women constituted 79% of the sarcoidosis patients and female gender ratio of sarcoidosis group was significantly higher than the tuberculosis and control group (p < 0.001). Demographic characteristics of patients were shown in Table   1 (Table 1) .
ESR and CRP values were lowest in the control group (p < 0.01 and p < 0.01). ESR and CRP values in sarcoidosis patients were lower than tuberculosis patients (respectively p < 0.01 and p < 0.01). Leukocyte (WBC) values were significantly lower in control and sarcoidosis patients than tuberculosis patients (p < 0.06 and p < 0.001 respectively). There was found no significant difference between control group and sarcoidosis group in terms of ESR, CRP and WBC levels (p > 0.05). PLT count of sarcoidosis patients was significantly lower than that of tuberculosis patients ( p < 0.001). PLT count of the patients in the control group were also significantly lower compared to the TB group (p < 0.001). Between sarcoidosis and control groups, there was was no statistically significant difference in terms of PLT count ( p > 0.05) . MPV measurements of tuberculosis cases were found significantly Duman 
was not differ significantly between sarcoidosis and control groups (p > 0.05). ESR, CRP, WBC, PLT and MPV values of the groups were shown in Table 2 (Table 2) .
Because PLT and MPV values of tuberculosis and sarcoidosis groups were found significantly different, it was considered to be calculated the most appropriate cut-off values in differiantial diagnosis of two diseases. In determining the cut-off points of PLT and MPV, diagnostic screening tests and ROC analysis were used.
In this study, the most appropriate cut-off value of PLT was determined as 300.000 to distinguish tuberculosis from sarcoidosis. For this cut-off value it was found to be sensitivity as 53.01 % ; specificity as 72.73 % ; positive predictive value as 61.97 % and negative predictive value as 64.86 % ( Figure 1-2) .
The best MPV cut-off value in differiantial diagnosis of tuberculosis and sarcoidosis was defined as 8,5. For this cut-off value for the diagnosis of tuberculosis sensitivity was found as 73,49 % ; specificity as 68,04 % ; positive predictive value as 66,30 % and negative predictive value as 75,00 % (Figure 3-4) .
DİSCUSSİON

Differiantial diagnosis of tuberculosis and sarcoidosis is still important issue because they
can mimic each other as in symptomatogy, both are granulomatous diseases pathologically but treatment of each diease was different (11) . Our findings provide novel information related to new biomarkers for differianting tuberculosis and sarcoidosis. In tuberculosis, CRP, ESR, WBC and PLT was found significantly higher than sarcoidosis. MPV was inversely correlated with inflammation and it was lower in tuberculosis patients. PLT > 300.000 and MPV < 8.5 values contribute to differiantiate tuberculosis from sarcoidosis.
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In most of the infectious and chronic infammatory diseases, reactive thrombocytosis can be seen as a systemic inflammatory response. In pneumonia, platelet response in antimicrobial host defense is similar to the leucocyte response and thrombocytosis should be considered as a poor clinical outcomes (1) . CRP is an acute-phase reactant secreted from hepatocytes in response to tissue damage or inflammation. The ESR , another acute phase reactant, has been found to be high in patients pneumonia and tuberculosis (13) . Robson et al defined severe pulmonary tuberculosis characterised immunologically by an acute phase response (14) . Reactive thrombocytosis developing in pulmonary tuberculosis has been shown to be correlated with acute phase reactans and severity of the disease (15, 16) .
In this study CRP,ESR,WBC and PLT were found higher in tuberculosis than in sarcoidosis and control groups. PLT was significantly higher in tuberculosis patients compared to sarcoidosis. In the comparison of tuberculosis and sarcoidosis, a cut-off value off PLT > 300.000 can differiante tuberculosis from sarcoidosis with 73% specificity.
MPV has attracted attention as a new inflammatory marker because it can be easily measured in routine complete blood count analysis, it's guick and cheap. MPV reflects platelet size and function and the size of platelets in circulation is affected by intensity of inflammation (9) .
The size of platelets decrease and smaller platelets released from bone marrow with overproduction of proinflammatory cytokines and acute phase reactans, so low MPV can be explained in this way (5) . MPV has been investigated in different chronic diseases and inverse corelation with inflammation has been demonstrated (7-10).
Howewer MPV is a little known marker for differiantiating sarcoidosis and tuberculosis. In the studies related to MPV in tuberculosis, MPV has been shown lower in active tuberculosis patients than control group (4, 17) . But in some studies MPV was found significantly higher in active tuberculosis patients and decreased with antituberculosis Duman et al 7 treatment (2, 16) . In present study MPV values of tuberculosis patients were significantly lower than that of sarcoidosis and control group. In Dirican et al's study MPV values was not differ significantly between sarcoidosis and control groups (18). Also in this study, MPV was similar in sarcoidosis and control groups but it was found significantly lower in tuberculosis group other than two groups. In the comparison of tuberculosis and sarcoidosis, a cut-off value off MPV < 8,5 can differiante tuberculosis from sarcoidosis with 68% specificity.
Limitations of present study are being retrospective, conducted in a single centre, based on hospital archive. Neverthless, the results from disese-specific study population studied at the largest chest disese teaching and research hospital in the region provide valuable clinic information for assesing PLT and MPV as new inflammatory biomarkers in differiantiation of tuberculosis and sarcoidosis.
CONCLUSİON
Differiantial diagnosis of tuberculosis and sarcoidosis are still very challenging. PLT and MPV are new inflammatory markers investigated as supportive markers for distinguishing two diseases. In present study PLT and MPV was found significantly different between tuberculosis and sarcoidosis groups. PLT > 300.000 and MPV < 8,5 values support the diagnosis of tuberculosis . Our findings support the idea that PLT and MPV could be used as a supportive marker for differiantion of tuberculosis from sarcoidosis. Future studies can be planned to clarify the utility of these markers in distinction of tuberculosis and sarcoidosis.
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